[
    {
        "Interacting DrugBank ID":"DB00408",
        "Interacting Drug Name":"Loxapine",
        "Interaction Description":"The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine."
    },
    {
        "Interacting DrugBank ID":"DB00255",
        "Interacting Drug Name":"Diethylstilbestrol",
        "Interaction Description":"Diethylstilbestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00269",
        "Interacting Drug Name":"Chlorotrianisene",
        "Interaction Description":"Chlorotrianisene may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00286",
        "Interacting Drug Name":"Conjugated estrogens",
        "Interaction Description":"Conjugated estrogens may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00655",
        "Interacting Drug Name":"Estrone",
        "Interaction Description":"Estrone may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00783",
        "Interacting Drug Name":"Estradiol",
        "Interaction Description":"Estradiol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00890",
        "Interacting Drug Name":"Dienestrol",
        "Interaction Description":"Dienestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00977",
        "Interacting Drug Name":"Ethinylestradiol",
        "Interaction Description":"Ethinylestradiol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB01357",
        "Interacting Drug Name":"Mestranol",
        "Interaction Description":"Mestranol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB04573",
        "Interacting Drug Name":"Estriol",
        "Interaction Description":"Estriol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB04574",
        "Interacting Drug Name":"Estrone sulfate",
        "Interaction Description":"Estrone sulfate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB04575",
        "Interacting Drug Name":"Quinestrol",
        "Interaction Description":"Quinestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB07931",
        "Interacting Drug Name":"Hexestrol",
        "Interaction Description":"Hexestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB09070",
        "Interacting Drug Name":"Tibolone",
        "Interaction Description":"Tibolone may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB09317",
        "Interacting Drug Name":"Synthetic Conjugated Estrogens, A",
        "Interaction Description":"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB09318",
        "Interacting Drug Name":"Synthetic Conjugated Estrogens, B",
        "Interaction Description":"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB09369",
        "Interacting Drug Name":"Polyestradiol phosphate",
        "Interaction Description":"Polyestradiol phosphate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB09381",
        "Interacting Drug Name":"Esterified estrogens",
        "Interaction Description":"Esterified estrogens may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB11478",
        "Interacting Drug Name":"Zeranol",
        "Interaction Description":"Zeranol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB11674",
        "Interacting Drug Name":"Equol",
        "Interaction Description":"Equol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB12487",
        "Interacting Drug Name":"Promestriene",
        "Interaction Description":"Promestriene may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13143",
        "Interacting Drug Name":"Methallenestril",
        "Interaction Description":"Methallenestril may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13386",
        "Interacting Drug Name":"Epimestrol",
        "Interaction Description":"Epimestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13418",
        "Interacting Drug Name":"Moxestrol",
        "Interaction Description":"Moxestrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13952",
        "Interacting Drug Name":"Estradiol acetate",
        "Interaction Description":"Estradiol acetate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13953",
        "Interacting Drug Name":"Estradiol benzoate",
        "Interaction Description":"Estradiol benzoate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13954",
        "Interacting Drug Name":"Estradiol cypionate",
        "Interaction Description":"Estradiol cypionate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13956",
        "Interacting Drug Name":"Estradiol valerate",
        "Interaction Description":"Estradiol valerate may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB15334",
        "Interacting Drug Name":"Biochanin A",
        "Interaction Description":"Biochanin A may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB15335",
        "Interacting Drug Name":"Formononetin",
        "Interaction Description":"Formononetin may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB12235",
        "Interacting Drug Name":"Estetrol",
        "Interaction Description":"Estetrol may increase the thrombogenic activities of Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00002",
        "Interacting Drug Name":"Cetuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00028",
        "Interacting Drug Name":"Human immunoglobulin G",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00051",
        "Interacting Drug Name":"Adalimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab."
    },
    {
        "Interacting DrugBank ID":"DB00054",
        "Interacting Drug Name":"Abciximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab."
    },
    {
        "Interacting DrugBank ID":"DB00056",
        "Interacting Drug Name":"Gemtuzumab ozogamicin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gemtuzumab ozogamicin."
    },
    {
        "Interacting DrugBank ID":"DB00057",
        "Interacting Drug Name":"Indium In-111 satumomab pendetide",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Indium In-111 satumomab pendetide."
    },
    {
        "Interacting DrugBank ID":"DB00065",
        "Interacting Drug Name":"Infliximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Infliximab."
    },
    {
        "Interacting DrugBank ID":"DB00072",
        "Interacting Drug Name":"Trastuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab."
    },
    {
        "Interacting DrugBank ID":"DB00073",
        "Interacting Drug Name":"Rituximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rituximab."
    },
    {
        "Interacting DrugBank ID":"DB00074",
        "Interacting Drug Name":"Basiliximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Basiliximab."
    },
    {
        "Interacting DrugBank ID":"DB00075",
        "Interacting Drug Name":"Muromonab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Muromonab."
    },
    {
        "Interacting DrugBank ID":"DB00076",
        "Interacting Drug Name":"Digoxin Immune Fab (Ovine)",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Digoxin Immune Fab (Ovine)."
    },
    {
        "Interacting DrugBank ID":"DB00078",
        "Interacting Drug Name":"Ibritumomab tiuxetan",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibritumomab tiuxetan."
    },
    {
        "Interacting DrugBank ID":"DB00081",
        "Interacting Drug Name":"Tositumomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab."
    },
    {
        "Interacting DrugBank ID":"DB00087",
        "Interacting Drug Name":"Alemtuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Alemtuzumab."
    },
    {
        "Interacting DrugBank ID":"DB00089",
        "Interacting Drug Name":"Capromab pendetide",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Capromab pendetide."
    },
    {
        "Interacting DrugBank ID":"DB00095",
        "Interacting Drug Name":"Efalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Efalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00098",
        "Interacting Drug Name":"Antithymocyte immunoglobulin (rabbit)",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Antithymocyte immunoglobulin (rabbit)."
    },
    {
        "Interacting DrugBank ID":"DB00108",
        "Interacting Drug Name":"Natalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Natalizumab."
    },
    {
        "Interacting DrugBank ID":"DB00110",
        "Interacting Drug Name":"Palivizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Palivizumab."
    },
    {
        "Interacting DrugBank ID":"DB00111",
        "Interacting Drug Name":"Daclizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Daclizumab."
    },
    {
        "Interacting DrugBank ID":"DB00112",
        "Interacting Drug Name":"Bevacizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab."
    },
    {
        "Interacting DrugBank ID":"DB00113",
        "Interacting Drug Name":"Technetium Tc-99m arcitumomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Technetium Tc-99m arcitumomab."
    },
    {
        "Interacting DrugBank ID":"DB01257",
        "Interacting Drug Name":"Eculizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab."
    },
    {
        "Interacting DrugBank ID":"DB01269",
        "Interacting Drug Name":"Panitumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab."
    },
    {
        "Interacting DrugBank ID":"DB01270",
        "Interacting Drug Name":"Ranibizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab."
    },
    {
        "Interacting DrugBank ID":"DB04901",
        "Interacting Drug Name":"Galiximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Galiximab."
    },
    {
        "Interacting DrugBank ID":"DB04949",
        "Interacting Drug Name":"Pexelizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pexelizumab."
    },
    {
        "Interacting DrugBank ID":"DB04956",
        "Interacting Drug Name":"Afelimomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Afelimomab."
    },
    {
        "Interacting DrugBank ID":"DB04958",
        "Interacting Drug Name":"Epratuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Epratuzumab."
    },
    {
        "Interacting DrugBank ID":"DB04962",
        "Interacting Drug Name":"Bectumomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bectumomab."
    },
    {
        "Interacting DrugBank ID":"DB04964",
        "Interacting Drug Name":"Oregovomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Oregovomab."
    },
    {
        "Interacting DrugBank ID":"DB04988",
        "Interacting Drug Name":"IGN311",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with IGN311."
    },
    {
        "Interacting DrugBank ID":"DB05006",
        "Interacting Drug Name":"Adecatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Adecatumumab."
    },
    {
        "Interacting DrugBank ID":"DB05097",
        "Interacting Drug Name":"Labetuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab."
    },
    {
        "Interacting DrugBank ID":"DB05101",
        "Interacting Drug Name":"Matuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Matuzumab."
    },
    {
        "Interacting DrugBank ID":"DB05111",
        "Interacting Drug Name":"Fontolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fontolizumab."
    },
    {
        "Interacting DrugBank ID":"DB05136",
        "Interacting Drug Name":"Bavituximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bavituximab."
    },
    {
        "Interacting DrugBank ID":"DB05139",
        "Interacting Drug Name":"CR002",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with CR002."
    },
    {
        "Interacting DrugBank ID":"DB05209",
        "Interacting Drug Name":"Rozrolimupab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozrolimupab."
    },
    {
        "Interacting DrugBank ID":"DB05304",
        "Interacting Drug Name":"Girentuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Girentuximab."
    },
    {
        "Interacting DrugBank ID":"DB05336",
        "Interacting Drug Name":"Obiltoxaximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab."
    },
    {
        "Interacting DrugBank ID":"DB05405",
        "Interacting Drug Name":"XTL-001",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with XTL-001."
    },
    {
        "Interacting DrugBank ID":"DB05437",
        "Interacting Drug Name":"NAV 1800",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with NAV 1800."
    },
    {
        "Interacting DrugBank ID":"DB05459",
        "Interacting Drug Name":"Briakinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Briakinumab."
    },
    {
        "Interacting DrugBank ID":"DB05496",
        "Interacting Drug Name":"Otelixizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Otelixizumab."
    },
    {
        "Interacting DrugBank ID":"DB05545",
        "Interacting Drug Name":"AMG 108",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with AMG 108."
    },
    {
        "Interacting DrugBank ID":"DB05550",
        "Interacting Drug Name":"Iratumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Iratumumab."
    },
    {
        "Interacting DrugBank ID":"DB05555",
        "Interacting Drug Name":"Enokizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Enokizumab."
    },
    {
        "Interacting DrugBank ID":"DB05578",
        "Interacting Drug Name":"Ramucirumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab."
    },
    {
        "Interacting DrugBank ID":"DB05595",
        "Interacting Drug Name":"Farletuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab."
    },
    {
        "Interacting DrugBank ID":"DB05656",
        "Interacting Drug Name":"Veltuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab."
    },
    {
        "Interacting DrugBank ID":"DB05679",
        "Interacting Drug Name":"Ustekinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab."
    },
    {
        "Interacting DrugBank ID":"DB05773",
        "Interacting Drug Name":"Trastuzumab emtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab emtansine."
    },
    {
        "Interacting DrugBank ID":"DB05793",
        "Interacting Drug Name":"PRO-542",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542."
    },
    {
        "Interacting DrugBank ID":"DB05797",
        "Interacting Drug Name":"TNX-901",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901."
    },
    {
        "Interacting DrugBank ID":"DB05889",
        "Interacting Drug Name":"Inotuzumab ozogamicin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin."
    },
    {
        "Interacting DrugBank ID":"DB05892",
        "Interacting Drug Name":"RI 624",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624."
    },
    {
        "Interacting DrugBank ID":"DB05915",
        "Interacting Drug Name":"Stamulumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029."
    },
    {
        "Interacting DrugBank ID":"DB05916",
        "Interacting Drug Name":"CT-011",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011."
    },
    {
        "Interacting DrugBank ID":"DB05941",
        "Interacting Drug Name":"Leronlimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab."
    },
    {
        "Interacting DrugBank ID":"DB05996",
        "Interacting Drug Name":"Glembatumumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB06043",
        "Interacting Drug Name":"Olaratumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab."
    },
    {
        "Interacting DrugBank ID":"DB06049",
        "Interacting Drug Name":"IPH 2101",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101."
    },
    {
        "Interacting DrugBank ID":"DB06050",
        "Interacting Drug Name":"TB-402",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402."
    },
    {
        "Interacting DrugBank ID":"DB06081",
        "Interacting Drug Name":"Caplacizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab."
    },
    {
        "Interacting DrugBank ID":"DB06101",
        "Interacting Drug Name":"IMC-1C11",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11."
    },
    {
        "Interacting DrugBank ID":"DB06116",
        "Interacting Drug Name":"Eldelumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab."
    },
    {
        "Interacting DrugBank ID":"DB06162",
        "Interacting Drug Name":"Lumiliximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab."
    },
    {
        "Interacting DrugBank ID":"DB06168",
        "Interacting Drug Name":"Canakinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab."
    },
    {
        "Interacting DrugBank ID":"DB06186",
        "Interacting Drug Name":"Ipilimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab."
    },
    {
        "Interacting DrugBank ID":"DB06192",
        "Interacting Drug Name":"Nimotuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab."
    },
    {
        "Interacting DrugBank ID":"DB06241",
        "Interacting Drug Name":"Clenoliximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab."
    },
    {
        "Interacting DrugBank ID":"DB06273",
        "Interacting Drug Name":"Tocilizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab."
    },
    {
        "Interacting DrugBank ID":"DB06304",
        "Interacting Drug Name":"BIIB015",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with BIIB015."
    },
    {
        "Interacting DrugBank ID":"DB06305",
        "Interacting Drug Name":"Sonepcizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sonepcizumab."
    },
    {
        "Interacting DrugBank ID":"DB06310",
        "Interacting Drug Name":"Motavizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Motavizumab."
    },
    {
        "Interacting DrugBank ID":"DB06317",
        "Interacting Drug Name":"Elotuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Elotuzumab."
    },
    {
        "Interacting DrugBank ID":"DB06318",
        "Interacting Drug Name":"AVE9633",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633."
    },
    {
        "Interacting DrugBank ID":"DB06322",
        "Interacting Drug Name":"Carotuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Carotuximab."
    },
    {
        "Interacting DrugBank ID":"DB06324",
        "Interacting Drug Name":"XmAb 2513",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with XmAb 2513."
    },
    {
        "Interacting DrugBank ID":"DB06342",
        "Interacting Drug Name":"Coltuximab ravtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Coltuximab ravtansine."
    },
    {
        "Interacting DrugBank ID":"DB06360",
        "Interacting Drug Name":"Lucatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lucatumumab."
    },
    {
        "Interacting DrugBank ID":"DB06366",
        "Interacting Drug Name":"Pertuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pertuzumab."
    },
    {
        "Interacting DrugBank ID":"DB06371",
        "Interacting Drug Name":"Siplizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Siplizumab."
    },
    {
        "Interacting DrugBank ID":"DB06467",
        "Interacting Drug Name":"Apolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Apolizumab."
    },
    {
        "Interacting DrugBank ID":"DB06474",
        "Interacting Drug Name":"Sibrotuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sibrotuzumab."
    },
    {
        "Interacting DrugBank ID":"DB06550",
        "Interacting Drug Name":"Bivatuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bivatuzumab."
    },
    {
        "Interacting DrugBank ID":"DB06557",
        "Interacting Drug Name":"Lerdelimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lerdelimumab."
    },
    {
        "Interacting DrugBank ID":"DB06599",
        "Interacting Drug Name":"Lexatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lexatumumab."
    },
    {
        "Interacting DrugBank ID":"DB06602",
        "Interacting Drug Name":"Reslizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Reslizumab."
    },
    {
        "Interacting DrugBank ID":"DB06606",
        "Interacting Drug Name":"Teplizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Teplizumab."
    },
    {
        "Interacting DrugBank ID":"DB06607",
        "Interacting Drug Name":"Catumaxomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Catumaxomab."
    },
    {
        "Interacting DrugBank ID":"DB06612",
        "Interacting Drug Name":"Mepolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mepolizumab."
    },
    {
        "Interacting DrugBank ID":"DB06643",
        "Interacting Drug Name":"Denosumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Denosumab."
    },
    {
        "Interacting DrugBank ID":"DB06647",
        "Interacting Drug Name":"Volociximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Volociximab."
    },
    {
        "Interacting DrugBank ID":"DB06650",
        "Interacting Drug Name":"Ofatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab."
    },
    {
        "Interacting DrugBank ID":"DB06674",
        "Interacting Drug Name":"Golimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Golimumab."
    },
    {
        "Interacting DrugBank ID":"DB08870",
        "Interacting Drug Name":"Brentuximab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB08879",
        "Interacting Drug Name":"Belimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Belimumab."
    },
    {
        "Interacting DrugBank ID":"DB08902",
        "Interacting Drug Name":"Raxibacumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab."
    },
    {
        "Interacting DrugBank ID":"DB08935",
        "Interacting Drug Name":"Obinutuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab."
    },
    {
        "Interacting DrugBank ID":"DB09029",
        "Interacting Drug Name":"Secukinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Secukinumab."
    },
    {
        "Interacting DrugBank ID":"DB09033",
        "Interacting Drug Name":"Vedolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab."
    },
    {
        "Interacting DrugBank ID":"DB09035",
        "Interacting Drug Name":"Nivolumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab."
    },
    {
        "Interacting DrugBank ID":"DB09036",
        "Interacting Drug Name":"Siltuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Siltuximab."
    },
    {
        "Interacting DrugBank ID":"DB09037",
        "Interacting Drug Name":"Pembrolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pembrolizumab."
    },
    {
        "Interacting DrugBank ID":"DB09045",
        "Interacting Drug Name":"Dulaglutide",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dulaglutide."
    },
    {
        "Interacting DrugBank ID":"DB09052",
        "Interacting Drug Name":"Blinatumomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Blinatumomab."
    },
    {
        "Interacting DrugBank ID":"DB09057",
        "Interacting Drug Name":"Anthrax immune globulin human",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Anthrax immune globulin human."
    },
    {
        "Interacting DrugBank ID":"DB09077",
        "Interacting Drug Name":"Dinutuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dinutuximab."
    },
    {
        "Interacting DrugBank ID":"DB09105",
        "Interacting Drug Name":"Asfotase alfa",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Asfotase alfa."
    },
    {
        "Interacting DrugBank ID":"DB09264",
        "Interacting Drug Name":"Idarucizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Idarucizumab."
    },
    {
        "Interacting DrugBank ID":"DB09302",
        "Interacting Drug Name":"Alirocumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Alirocumab."
    },
    {
        "Interacting DrugBank ID":"DB09303",
        "Interacting Drug Name":"Evolocumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Evolocumab."
    },
    {
        "Interacting DrugBank ID":"DB09312",
        "Interacting Drug Name":"Antilymphocyte immunoglobulin (horse)",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Antilymphocyte immunoglobulin (horse)."
    },
    {
        "Interacting DrugBank ID":"DB09331",
        "Interacting Drug Name":"Daratumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Daratumumab."
    },
    {
        "Interacting DrugBank ID":"DB09559",
        "Interacting Drug Name":"Necitumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab."
    },
    {
        "Interacting DrugBank ID":"DB11569",
        "Interacting Drug Name":"Ixekizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ixekizumab."
    },
    {
        "Interacting DrugBank ID":"DB11580",
        "Interacting Drug Name":"Ravulizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ravulizumab."
    },
    {
        "Interacting DrugBank ID":"DB11595",
        "Interacting Drug Name":"Atezolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Atezolizumab."
    },
    {
        "Interacting DrugBank ID":"DB11604",
        "Interacting Drug Name":"Tetanus immune globulin, human",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tetanus immune globulin, human."
    },
    {
        "Interacting DrugBank ID":"DB11608",
        "Interacting Drug Name":"Eftrenonacog alfa",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Eftrenonacog alfa."
    },
    {
        "Interacting DrugBank ID":"DB11621",
        "Interacting Drug Name":"Human varicella-zoster immune globulin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Human varicella-zoster immune globulin."
    },
    {
        "Interacting DrugBank ID":"DB11646",
        "Interacting Drug Name":"Conatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Conatumumab."
    },
    {
        "Interacting DrugBank ID":"DB11657",
        "Interacting Drug Name":"Tabalumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tabalumab."
    },
    {
        "Interacting DrugBank ID":"DB11680",
        "Interacting Drug Name":"Ficlatuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ficlatuzumab."
    },
    {
        "Interacting DrugBank ID":"DB11685",
        "Interacting Drug Name":"Figitumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Figitumumab."
    },
    {
        "Interacting DrugBank ID":"DB11714",
        "Interacting Drug Name":"Durvalumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Durvalumab."
    },
    {
        "Interacting DrugBank ID":"DB11715",
        "Interacting Drug Name":"Bapineuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bapineuzumab."
    },
    {
        "Interacting DrugBank ID":"DB11731",
        "Interacting Drug Name":"Depatuxizumab mafodotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab mafodotin."
    },
    {
        "Interacting DrugBank ID":"DB11746",
        "Interacting Drug Name":"Onartuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Onartuzumab."
    },
    {
        "Interacting DrugBank ID":"DB11756",
        "Interacting Drug Name":"Solanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Solanezumab."
    },
    {
        "Interacting DrugBank ID":"DB11767",
        "Interacting Drug Name":"Sarilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sarilumab."
    },
    {
        "Interacting DrugBank ID":"DB11771",
        "Interacting Drug Name":"Tremelimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tremelimumab."
    },
    {
        "Interacting DrugBank ID":"DB11776",
        "Interacting Drug Name":"Brodalumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Brodalumab."
    },
    {
        "Interacting DrugBank ID":"DB11803",
        "Interacting Drug Name":"Sirukumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sirukumab."
    },
    {
        "Interacting DrugBank ID":"DB11826",
        "Interacting Drug Name":"Lampalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lampalizumab."
    },
    {
        "Interacting DrugBank ID":"DB11834",
        "Interacting Drug Name":"Guselkumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Guselkumab."
    },
    {
        "Interacting DrugBank ID":"DB11840",
        "Interacting Drug Name":"Dalotuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalotuzumab."
    },
    {
        "Interacting DrugBank ID":"DB11849",
        "Interacting Drug Name":"Emibetuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Emibetuzumab."
    },
    {
        "Interacting DrugBank ID":"DB11850",
        "Interacting Drug Name":"Ublituximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ublituximab."
    },
    {
        "Interacting DrugBank ID":"DB11856",
        "Interacting Drug Name":"Ligelizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ligelizumab."
    },
    {
        "Interacting DrugBank ID":"DB11857",
        "Interacting Drug Name":"Seribantumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Seribantumab."
    },
    {
        "Interacting DrugBank ID":"DB11862",
        "Interacting Drug Name":"Landogrozumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Landogrozumab."
    },
    {
        "Interacting DrugBank ID":"DB11866",
        "Interacting Drug Name":"Romosozumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Romosozumab."
    },
    {
        "Interacting DrugBank ID":"DB11884",
        "Interacting Drug Name":"Vadastuximab talirine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vadastuximab talirine."
    },
    {
        "Interacting DrugBank ID":"DB11914",
        "Interacting Drug Name":"Lebrikizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab."
    },
    {
        "Interacting DrugBank ID":"DB11930",
        "Interacting Drug Name":"Varlilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Varlilumab."
    },
    {
        "Interacting DrugBank ID":"DB11945",
        "Interacting Drug Name":"Avelumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Avelumab."
    },
    {
        "Interacting DrugBank ID":"DB11959",
        "Interacting Drug Name":"Crenezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Crenezumab."
    },
    {
        "Interacting DrugBank ID":"DB11972",
        "Interacting Drug Name":"Rilotumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rilotumumab."
    },
    {
        "Interacting DrugBank ID":"DB11976",
        "Interacting Drug Name":"Anifrolumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Anifrolumab."
    },
    {
        "Interacting DrugBank ID":"DB11988",
        "Interacting Drug Name":"Ocrelizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ocrelizumab."
    },
    {
        "Interacting DrugBank ID":"DB12023",
        "Interacting Drug Name":"Benralizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab."
    },
    {
        "Interacting DrugBank ID":"DB12034",
        "Interacting Drug Name":"Gantenerumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gantenerumab."
    },
    {
        "Interacting DrugBank ID":"DB12053",
        "Interacting Drug Name":"Visilizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Visilizumab."
    },
    {
        "Interacting DrugBank ID":"DB12077",
        "Interacting Drug Name":"Urelumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab."
    },
    {
        "Interacting DrugBank ID":"DB12089",
        "Interacting Drug Name":"Lorvotuzumab mertansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorvotuzumab mertansine."
    },
    {
        "Interacting DrugBank ID":"DB12090",
        "Interacting Drug Name":"Patritumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Patritumab."
    },
    {
        "Interacting DrugBank ID":"DB12102",
        "Interacting Drug Name":"Fulranumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fulranumab."
    },
    {
        "Interacting DrugBank ID":"DB12104",
        "Interacting Drug Name":"Tarextumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tarextumab."
    },
    {
        "Interacting DrugBank ID":"DB12118",
        "Interacting Drug Name":"Sotatercept",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept."
    },
    {
        "Interacting DrugBank ID":"DB12119",
        "Interacting Drug Name":"Gevokizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab."
    },
    {
        "Interacting DrugBank ID":"DB12142",
        "Interacting Drug Name":"Duligotuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Duligotuzumab."
    },
    {
        "Interacting DrugBank ID":"DB12152",
        "Interacting Drug Name":"Simtuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Simtuzumab."
    },
    {
        "Interacting DrugBank ID":"DB12157",
        "Interacting Drug Name":"Fasinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fasinumab."
    },
    {
        "Interacting DrugBank ID":"DB12159",
        "Interacting Drug Name":"Dupilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dupilumab."
    },
    {
        "Interacting DrugBank ID":"DB12169",
        "Interacting Drug Name":"Tralokinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab."
    },
    {
        "Interacting DrugBank ID":"DB12189",
        "Interacting Drug Name":"Etrolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Etrolizumab."
    },
    {
        "Interacting DrugBank ID":"DB12202",
        "Interacting Drug Name":"Zalutumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Zalutumumab."
    },
    {
        "Interacting DrugBank ID":"DB12205",
        "Interacting Drug Name":"Ganitumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ganitumab."
    },
    {
        "Interacting DrugBank ID":"DB12213",
        "Interacting Drug Name":"Etaracizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Etaracizumab."
    },
    {
        "Interacting DrugBank ID":"DB12240",
        "Interacting Drug Name":"Polatuzumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Polatuzumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB12246",
        "Interacting Drug Name":"Inclacumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Inclacumab."
    },
    {
        "Interacting DrugBank ID":"DB12250",
        "Interacting Drug Name":"Cixutumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab."
    },
    {
        "Interacting DrugBank ID":"DB12261",
        "Interacting Drug Name":"Ascrinvacumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ascrinvacumab."
    },
    {
        "Interacting DrugBank ID":"DB12274",
        "Interacting Drug Name":"Aducanumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Aducanumab."
    },
    {
        "Interacting DrugBank ID":"DB12296",
        "Interacting Drug Name":"GS-5745",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with GS-5745."
    },
    {
        "Interacting DrugBank ID":"DB12317",
        "Interacting Drug Name":"Vanucizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vanucizumab."
    },
    {
        "Interacting DrugBank ID":"DB12331",
        "Interacting Drug Name":"Labetuzumab govitecan",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab govitecan."
    },
    {
        "Interacting DrugBank ID":"DB12335",
        "Interacting Drug Name":"Tanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tanezumab."
    },
    {
        "Interacting DrugBank ID":"DB12342",
        "Interacting Drug Name":"Ensituximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ensituximab."
    },
    {
        "Interacting DrugBank ID":"DB12344",
        "Interacting Drug Name":"Fezakinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fezakinumab."
    },
    {
        "Interacting DrugBank ID":"DB12363",
        "Interacting Drug Name":"Dusigitumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dusigitumab."
    },
    {
        "Interacting DrugBank ID":"DB12396",
        "Interacting Drug Name":"Fresolimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fresolimumab."
    },
    {
        "Interacting DrugBank ID":"DB12413",
        "Interacting Drug Name":"Indusatumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Indusatumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB12456",
        "Interacting Drug Name":"Bococizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bococizumab."
    },
    {
        "Interacting DrugBank ID":"DB12489",
        "Interacting Drug Name":"Mirvetuximab soravtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mirvetuximab Soravtansine."
    },
    {
        "Interacting DrugBank ID":"DB12498",
        "Interacting Drug Name":"Mogamulizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mogamulizumab."
    },
    {
        "Interacting DrugBank ID":"DB12520",
        "Interacting Drug Name":"Plozalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Plozalizumab."
    },
    {
        "Interacting DrugBank ID":"DB12530",
        "Interacting Drug Name":"Inebilizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Inebilizumab."
    },
    {
        "Interacting DrugBank ID":"DB12534",
        "Interacting Drug Name":"Mavrilimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mavrilimumab."
    },
    {
        "Interacting DrugBank ID":"DB12560",
        "Interacting Drug Name":"Blosozumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Blosozumab."
    },
    {
        "Interacting DrugBank ID":"DB12584",
        "Interacting Drug Name":"Bimagrumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimagrumab."
    },
    {
        "Interacting DrugBank ID":"DB12589",
        "Interacting Drug Name":"Dacetuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dacetuzumab."
    },
    {
        "Interacting DrugBank ID":"DB12609",
        "Interacting Drug Name":"Tovetumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tovetumab."
    },
    {
        "Interacting DrugBank ID":"DB12683",
        "Interacting Drug Name":"Lumretuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumretuzumab."
    },
    {
        "Interacting DrugBank ID":"DB12698",
        "Interacting Drug Name":"Ibalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibalizumab."
    },
    {
        "Interacting DrugBank ID":"DB12701",
        "Interacting Drug Name":"Intetumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Intetumumab."
    },
    {
        "Interacting DrugBank ID":"DB12718",
        "Interacting Drug Name":"Carlumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Carlumab."
    },
    {
        "Interacting DrugBank ID":"DB12734",
        "Interacting Drug Name":"Demcizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Demcizumab."
    },
    {
        "Interacting DrugBank ID":"DB12773",
        "Interacting Drug Name":"Sifalimumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab."
    },
    {
        "Interacting DrugBank ID":"DB12775",
        "Interacting Drug Name":"Abituzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Abituzumab."
    },
    {
        "Interacting DrugBank ID":"DB12797",
        "Interacting Drug Name":"Ecromeximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ecromeximab."
    },
    {
        "Interacting DrugBank ID":"DB12807",
        "Interacting Drug Name":"Naptumomab estafenatox",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Naptumomab estafenatox."
    },
    {
        "Interacting DrugBank ID":"DB12815",
        "Interacting Drug Name":"Crotedumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Crotedumab."
    },
    {
        "Interacting DrugBank ID":"DB12820",
        "Interacting Drug Name":"Concizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Concizumab."
    },
    {
        "Interacting DrugBank ID":"DB12826",
        "Interacting Drug Name":"Depatuxizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab."
    },
    {
        "Interacting DrugBank ID":"DB12844",
        "Interacting Drug Name":"Rontalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rontalizumab."
    },
    {
        "Interacting DrugBank ID":"DB12845",
        "Interacting Drug Name":"Amatuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab."
    },
    {
        "Interacting DrugBank ID":"DB12849",
        "Interacting Drug Name":"Clazakizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Clazakizumab."
    },
    {
        "Interacting DrugBank ID":"DB12891",
        "Interacting Drug Name":"Ozanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ozanezumab."
    },
    {
        "Interacting DrugBank ID":"DB12893",
        "Interacting Drug Name":"Sacituzumab govitecan",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sacituzumab govitecan."
    },
    {
        "Interacting DrugBank ID":"DB12917",
        "Interacting Drug Name":"Bimekizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimekizumab."
    },
    {
        "Interacting DrugBank ID":"DB12943",
        "Interacting Drug Name":"Milatuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Milatuzumab."
    },
    {
        "Interacting DrugBank ID":"DB12976",
        "Interacting Drug Name":"Robatumumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Robatumumab."
    },
    {
        "Interacting DrugBank ID":"DB13017",
        "Interacting Drug Name":"Rovalpituzumab tesirine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rovalpituzumab tesirine."
    },
    {
        "Interacting DrugBank ID":"DB13037",
        "Interacting Drug Name":"Namilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Namilumab."
    },
    {
        "Interacting DrugBank ID":"DB13045",
        "Interacting Drug Name":"Racotumomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Racotumomab."
    },
    {
        "Interacting DrugBank ID":"DB13073",
        "Interacting Drug Name":"Tregalizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tregalizumab."
    },
    {
        "Interacting DrugBank ID":"DB13127",
        "Interacting Drug Name":"Olokizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Olokizumab."
    },
    {
        "Interacting DrugBank ID":"DB13140",
        "Interacting Drug Name":"Bezlotoxumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bezlotoxumab."
    },
    {
        "Interacting DrugBank ID":"DB13375",
        "Interacting Drug Name":"Edrecolomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Edrecolomab."
    },
    {
        "Interacting DrugBank ID":"DB13535",
        "Interacting Drug Name":"Nebacumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Nebacumab."
    },
    {
        "Interacting DrugBank ID":"DB13886",
        "Interacting Drug Name":"Human cytomegalovirus immune globulin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Human cytomegalovirus immune globulin."
    },
    {
        "Interacting DrugBank ID":"DB13923",
        "Interacting Drug Name":"Emicizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Emicizumab."
    },
    {
        "Interacting DrugBank ID":"DB13976",
        "Interacting Drug Name":"Sulesomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sulesomab."
    },
    {
        "Interacting DrugBank ID":"DB13979",
        "Interacting Drug Name":"Besilesomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Besilesomab."
    },
    {
        "Interacting DrugBank ID":"DB14004",
        "Interacting Drug Name":"Tildrakizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tildrakizumab."
    },
    {
        "Interacting DrugBank ID":"DB14012",
        "Interacting Drug Name":"Burosumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Burosumab."
    },
    {
        "Interacting DrugBank ID":"DB14039",
        "Interacting Drug Name":"Erenumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Erenumab."
    },
    {
        "Interacting DrugBank ID":"DB14040",
        "Interacting Drug Name":"Eptinezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Eptinezumab."
    },
    {
        "Interacting DrugBank ID":"DB14041",
        "Interacting Drug Name":"Fremanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fremanezumab."
    },
    {
        "Interacting DrugBank ID":"DB14042",
        "Interacting Drug Name":"Galcanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Galcanezumab."
    },
    {
        "Interacting DrugBank ID":"DB14211",
        "Interacting Drug Name":"Fanolesomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Fanolesomab."
    },
    {
        "Interacting DrugBank ID":"DB14580",
        "Interacting Drug Name":"Lecanemab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lecanemab."
    },
    {
        "Interacting DrugBank ID":"DB14597",
        "Interacting Drug Name":"Lanadelumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lanadelumab."
    },
    {
        "Interacting DrugBank ID":"DB14707",
        "Interacting Drug Name":"Cemiplimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Cemiplimab."
    },
    {
        "Interacting DrugBank ID":"DB14724",
        "Interacting Drug Name":"Emapalumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Emapalumab."
    },
    {
        "Interacting DrugBank ID":"DB14762",
        "Interacting Drug Name":"Risankizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Risankizumab."
    },
    {
        "Interacting DrugBank ID":"DB14776",
        "Interacting Drug Name":"Camrelizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Camrelizumab."
    },
    {
        "Interacting DrugBank ID":"DB14778",
        "Interacting Drug Name":"Setrusumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Setrusumab."
    },
    {
        "Interacting DrugBank ID":"DB14784",
        "Interacting Drug Name":"Gancotamab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gancotamab."
    },
    {
        "Interacting DrugBank ID":"DB14809",
        "Interacting Drug Name":"Anetumab ravtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Anetumab ravtansine."
    },
    {
        "Interacting DrugBank ID":"DB14811",
        "Interacting Drug Name":"Isatuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Isatuximab."
    },
    {
        "Interacting DrugBank ID":"DB14824",
        "Interacting Drug Name":"Icrucumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Icrucumab."
    },
    {
        "Interacting DrugBank ID":"DB14843",
        "Interacting Drug Name":"Codrituzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Codrituzumab."
    },
    {
        "Interacting DrugBank ID":"DB14864",
        "Interacting Drug Name":"Brolucizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Brolucizumab."
    },
    {
        "Interacting DrugBank ID":"DB14871",
        "Interacting Drug Name":"Xentuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Xentuzumab."
    },
    {
        "Interacting DrugBank ID":"DB14877",
        "Interacting Drug Name":"Lintuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lintuzumab."
    },
    {
        "Interacting DrugBank ID":"DB14891",
        "Interacting Drug Name":"Vobarilizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vobarilizumab."
    },
    {
        "Interacting DrugBank ID":"DB14897",
        "Interacting Drug Name":"Parsatuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Parsatuzumab."
    },
    {
        "Interacting DrugBank ID":"DB14905",
        "Interacting Drug Name":"Emactuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Emactuzumab."
    },
    {
        "Interacting DrugBank ID":"DB14907",
        "Interacting Drug Name":"Bevacizumab zirconium Zr-89",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab zirconium Zr-89."
    },
    {
        "Interacting DrugBank ID":"DB14908",
        "Interacting Drug Name":"Refanezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Refanezumab."
    },
    {
        "Interacting DrugBank ID":"DB14919",
        "Interacting Drug Name":"Rozanolixizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozanolixizumab."
    },
    {
        "Interacting DrugBank ID":"DB14947",
        "Interacting Drug Name":"Bermekimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bermekimab."
    },
    {
        "Interacting DrugBank ID":"DB14952",
        "Interacting Drug Name":"Pamrevlumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pamrevlumab."
    },
    {
        "Interacting DrugBank ID":"DB14959",
        "Interacting Drug Name":"Opicinumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Opicinumab."
    },
    {
        "Interacting DrugBank ID":"DB14962",
        "Interacting Drug Name":"Trastuzumab deruxtecan",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab deruxtecan."
    },
    {
        "Interacting DrugBank ID":"DB14967",
        "Interacting Drug Name":"Margetuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Margetuximab."
    },
    {
        "Interacting DrugBank ID":"DB14988",
        "Interacting Drug Name":"Dalantercept",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalantercept."
    },
    {
        "Interacting DrugBank ID":"DB14997",
        "Interacting Drug Name":"Pateclizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pateclizumab."
    },
    {
        "Interacting DrugBank ID":"DB15014",
        "Interacting Drug Name":"Gremubamab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gremubamab."
    },
    {
        "Interacting DrugBank ID":"DB15022",
        "Interacting Drug Name":"Apomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Apomab."
    },
    {
        "Interacting DrugBank ID":"DB15044",
        "Interacting Drug Name":"Tafasitamab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tafasitamab."
    },
    {
        "Interacting DrugBank ID":"DB15045",
        "Interacting Drug Name":"Ipafricept",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipafricept."
    },
    {
        "Interacting DrugBank ID":"DB15076",
        "Interacting Drug Name":"Abrilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Abrilumab."
    },
    {
        "Interacting DrugBank ID":"DB15089",
        "Interacting Drug Name":"Frovocimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Frovocimab."
    },
    {
        "Interacting DrugBank ID":"DB15090",
        "Interacting Drug Name":"Tezepelumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tezepelumab."
    },
    {
        "Interacting DrugBank ID":"DB15101",
        "Interacting Drug Name":"Tigatuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tigatuzumab."
    },
    {
        "Interacting DrugBank ID":"DB15104",
        "Interacting Drug Name":"Telisotuzumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Telisotuzumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB15113",
        "Interacting Drug Name":"Utomilumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Utomilumab."
    },
    {
        "Interacting DrugBank ID":"DB15118",
        "Interacting Drug Name":"Zolbetuximab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Zolbetuximab."
    },
    {
        "Interacting DrugBank ID":"DB15135",
        "Interacting Drug Name":"Ponezumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ponezumab."
    },
    {
        "Interacting DrugBank ID":"DB15160",
        "Interacting Drug Name":"Asunercept",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Asunercept."
    },
    {
        "Interacting DrugBank ID":"DB15172",
        "Interacting Drug Name":"Suvratoxumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Suvratoxumab."
    },
    {
        "Interacting DrugBank ID":"DB15225",
        "Interacting Drug Name":"Mitazalimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mitazalimab."
    },
    {
        "Interacting DrugBank ID":"DB15252",
        "Interacting Drug Name":"Nemolizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Nemolizumab."
    },
    {
        "Interacting DrugBank ID":"DB15253",
        "Interacting Drug Name":"Bleselumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bleselumab."
    },
    {
        "Interacting DrugBank ID":"DB15277",
        "Interacting Drug Name":"Gedivumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Gedivumab."
    },
    {
        "Interacting DrugBank ID":"DB15336",
        "Interacting Drug Name":"Valanafusp alfa",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Valanafusp alfa."
    },
    {
        "Interacting DrugBank ID":"DB15349",
        "Interacting Drug Name":"Sofituzumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sofituzumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB15363",
        "Interacting Drug Name":"Istiratumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Istiratumab."
    },
    {
        "Interacting DrugBank ID":"DB15383",
        "Interacting Drug Name":"Pidilizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pidilizumab."
    },
    {
        "Interacting DrugBank ID":"DB15397",
        "Interacting Drug Name":"GMA-161",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with GMA-161."
    },
    {
        "Interacting DrugBank ID":"DB15409",
        "Interacting Drug Name":"Ladiratuzumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ladiratuzumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB15415",
        "Interacting Drug Name":"Tomaralimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tomaralimab."
    },
    {
        "Interacting DrugBank ID":"DB15428",
        "Interacting Drug Name":"Vesencumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vesencumab."
    },
    {
        "Interacting DrugBank ID":"DB15432",
        "Interacting Drug Name":"Pinatuzumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pinatuzumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB15441",
        "Interacting Drug Name":"Lulizumab pegol",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lulizumab pegol."
    },
    {
        "Interacting DrugBank ID":"DB15443",
        "Interacting Drug Name":"Lorukafusp alfa",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorukafusp alfa."
    },
    {
        "Interacting DrugBank ID":"DB15453",
        "Interacting Drug Name":"Naratuximab emtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Naratuximab emtansine."
    },
    {
        "Interacting DrugBank ID":"DB15559",
        "Interacting Drug Name":"Zenocutuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Zenocutuzumab."
    },
    {
        "Interacting DrugBank ID":"DB15898",
        "Interacting Drug Name":"Atoltivimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Atoltivimab."
    },
    {
        "Interacting DrugBank ID":"DB15899",
        "Interacting Drug Name":"Maftivimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Maftivimab."
    },
    {
        "Interacting DrugBank ID":"DB15900",
        "Interacting Drug Name":"Odesivimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Odesivimab."
    },
    {
        "Interacting DrugBank ID":"DB15719",
        "Interacting Drug Name":"Belantamab mafodotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Belantamab mafodotin."
    },
    {
        "Interacting DrugBank ID":"DB16385",
        "Interacting Drug Name":"Ansuvimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Ansuvimab."
    },
    {
        "Interacting DrugBank ID":"DB15718",
        "Interacting Drug Name":"Bamlanivimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bamlanivimab."
    },
    {
        "Interacting DrugBank ID":"DB05276",
        "Interacting Drug Name":"Hepatitis B immune globulin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Hepatitis B immune globulin."
    },
    {
        "Interacting DrugBank ID":"DB11597",
        "Interacting Drug Name":"Human Rho(D) immune globulin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Human Rho(D) immune globulin."
    },
    {
        "Interacting DrugBank ID":"DB15627",
        "Interacting Drug Name":"Dostarlimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Dostarlimab."
    },
    {
        "Interacting DrugBank ID":"DB08904",
        "Interacting Drug Name":"Certolizumab pegol",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Certolizumab pegol."
    },
    {
        "Interacting DrugBank ID":"DB15628",
        "Interacting Drug Name":"Inolimomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Inolimomab."
    },
    {
        "Interacting DrugBank ID":"DB15865",
        "Interacting Drug Name":"Pentaglobin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Pentaglobin."
    },
    {
        "Interacting DrugBank ID":"DB16077",
        "Interacting Drug Name":"Abagovomab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Abagovomab."
    },
    {
        "Interacting DrugBank ID":"DB16151",
        "Interacting Drug Name":"Efungumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Efungumab."
    },
    {
        "Interacting DrugBank ID":"DB16170",
        "Interacting Drug Name":"Foralumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Foralumab."
    },
    {
        "Interacting DrugBank ID":"DB16195",
        "Interacting Drug Name":"Indatuximab ravtansine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Indatuximab ravtansine."
    },
    {
        "Interacting DrugBank ID":"DB16225",
        "Interacting Drug Name":"Magrolimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Magrolimab."
    },
    {
        "Interacting DrugBank ID":"DB16265",
        "Interacting Drug Name":"Olinvacimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Olinvacimab."
    },
    {
        "Interacting DrugBank ID":"DB16376",
        "Interacting Drug Name":"Actoxumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Actoxumab."
    },
    {
        "Interacting DrugBank ID":"DB16421",
        "Interacting Drug Name":"Volagidemab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Volagidemab."
    },
    {
        "Interacting DrugBank ID":"DB16659",
        "Interacting Drug Name":"Bentracimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bentracimab."
    },
    {
        "Interacting DrugBank ID":"DB16695",
        "Interacting Drug Name":"Amivantamab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Amivantamab."
    },
    {
        "Interacting DrugBank ID":"DB15595",
        "Interacting Drug Name":"Ebola Zaire vaccine (live, attenuated)",
        "Interaction Description":"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB15258",
        "Interacting Drug Name":"Imlifidase",
        "Interaction Description":"The therapeutic efficacy of Omalizumab can be decreased when used in combination with Imlifidase."
    },
    {
        "Interacting DrugBank ID":"DB15940",
        "Interacting Drug Name":"Imdevimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Imdevimab."
    },
    {
        "Interacting DrugBank ID":"DB15941",
        "Interacting Drug Name":"Casirivimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Casirivimab."
    },
    {
        "Interacting DrugBank ID":"DB16393",
        "Interacting Drug Name":"Cilgavimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Cilgavimab."
    },
    {
        "Interacting DrugBank ID":"DB16394",
        "Interacting Drug Name":"Tixagevimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tixagevimab."
    },
    {
        "Interacting DrugBank ID":"DB16355",
        "Interacting Drug Name":"Sotrovimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotrovimab."
    },
    {
        "Interacting DrugBank ID":"DB16222",
        "Interacting Drug Name":"Loncastuximab tesirine",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Loncastuximab tesirine."
    },
    {
        "Interacting DrugBank ID":"DB16732",
        "Interacting Drug Name":"Tisotumab vedotin",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tisotumab vedotin."
    },
    {
        "Interacting DrugBank ID":"DB14996",
        "Interacting Drug Name":"Sutimlimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Sutimlimab."
    },
    {
        "Interacting DrugBank ID":"DB16755",
        "Interacting Drug Name":"Bebtelovimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Bebtelovimab."
    },
    {
        "Interacting DrugBank ID":"DB15434",
        "Interacting Drug Name":"Mosunetuzumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Mosunetuzumab."
    },
    {
        "Interacting DrugBank ID":"DB15626",
        "Interacting Drug Name":"Spesolimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Spesolimab."
    },
    {
        "Interacting DrugBank ID":"DB15001",
        "Interacting Drug Name":"Eflapegrastim",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Eflapegrastim."
    },
    {
        "Interacting DrugBank ID":"DB16371",
        "Interacting Drug Name":"Glofitamab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Glofitamab."
    },
    {
        "Interacting DrugBank ID":"DB14851",
        "Interacting Drug Name":"Relatlimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Relatlimab."
    },
    {
        "Interacting DrugBank ID":"DB16416",
        "Interacting Drug Name":"Vilobelimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Vilobelimab."
    },
    {
        "Interacting DrugBank ID":"DB15218",
        "Interacting Drug Name":"Pozelimab",
        "Interaction Description":"The serum concentration of Pozelimab can be decreased when it is combined with Omalizumab."
    },
    {
        "Interacting DrugBank ID":"DB15043",
        "Interacting Drug Name":"Toripalimab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Toripalimab."
    },
    {
        "Interacting DrugBank ID":"DB14922",
        "Interacting Drug Name":"Tislelizumab",
        "Interaction Description":"The risk or severity of adverse effects can be increased when Omalizumab is combined with Tislelizumab."
    }
]